Max Drawdown (5Y) Chart

View Max Drawdown (5Y) for PFE.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Max Drawdown (5Y) Chart
Start Trial

Historical Max Drawdown (5Y) Data

View and export this data back to 1990. Start Trial.
Date Value
July 31, 2026 58.95%
June 30, 2026 58.95%
May 31, 2026 58.95%
April 30, 2026 58.95%
March 31, 2026 58.95%
February 28, 2026 58.95%
January 31, 2026 58.95%
December 31, 2025 58.95%
November 30, 2025 58.95%
October 31, 2025 58.95%
September 30, 2025 58.95%
August 31, 2025 58.95%
July 31, 2025 58.95%
June 30, 2025 58.95%
May 31, 2025 58.95%
April 30, 2025 58.95%
March 31, 2025 54.78%
February 28, 2025 54.78%
January 31, 2025 54.78%
December 31, 2024 54.78%
November 30, 2024 54.78%
October 31, 2024 54.78%
September 30, 2024 54.78%
August 31, 2024 54.78%
July 31, 2024 54.78%
Date Value
June 30, 2024 54.78%
May 31, 2024 54.78%
April 30, 2024 54.78%
March 31, 2024 53.93%
February 29, 2024 53.93%
January 31, 2024 53.93%
December 31, 2023 53.93%
November 30, 2023 48.91%
October 31, 2023 47.64%
September 30, 2023 44.19%
August 31, 2023 39.13%
July 31, 2023 38.90%
June 30, 2023 37.89%
May 31, 2023 37.27%
April 30, 2023 35.44%
March 31, 2023 35.44%
February 28, 2023 35.44%
January 31, 2023 35.44%
December 31, 2022 35.44%
November 30, 2022 35.44%
October 31, 2022 35.44%
September 30, 2022 35.44%
August 31, 2022 35.44%
July 31, 2022 35.44%
June 30, 2022 35.44%

Max Drawdown Definition

Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.

Read full definition.

Max Drawdown (5Y) Range, Past 5 Years

View Max Drawdown (5Y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Max Drawdown (5Y) Benchmarks

View Max Drawdown (5Y) Benchmarks
Start Trial
Johnson & Johnson 18.44%
Eli Lilly & Co. 34.47%
Merck & Co., Inc. 43.45%
Bristol Myers Squibb Co. 47.67%
Viatris, Inc. 81.23%